Found a bug or want a feature? Verified reports earn free credits.
Log inSign up
Back to alerts
PAUSHAKLTDBSEPAUSHAK LIMITED· Chemicals & PetrochemicalsHighNeutral
Announced Thu, 30 Jul, 2026 · 16:22 IST

Paushak Q1 FY27 PAT up 25.5% YoY to Rs 15.1 cr, revenue jumps 49.5%

Revenue Growth 20pctPat Growth 25pctResults RestatedResults View source PDFExplain this filing

PAUSHAKLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+4.8%Reaction day
₹601.05
prior close
₹629.95
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.1%+3.7% vs market
Specialty Chemicals peers, median of 94sector+0.3%+4.5% vs sector

On the reaction day the stock moved 3.7 pts more than Nifty Microcap 250 and 4.5 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+5.4
10m
+4.5
15m
+2.8
30m
+1.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+4.8+1.1+3.7+0.3+4.5
Next day
+7.3+2.4+4.9+1.6+5.7
2d
+21.1+2.9+18.2+1.1+20.0
3d
+18.1+4.2+13.9+1.8+16.3
4d
+14.0+4.6+9.4+2.3+11.7
5d
+17.6+4.6+13.0+1.9+15.7
1w
+14.4+4.4+10.0+2.9+11.5
15d
+27.3+5.7+21.6+2.1+25.3
1m
+26.4+6.6+19.9+4.2+22.3
2m
+9.6+5.4+4.2+1.8+7.7
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 94Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Paushak Limited announced Q1 FY27 unaudited results. Revenue from operations rose 49.5% YoY to Rs 83.55 cr from Rs 55.88 cr. Total income came in at Rs 86.69 cr. Profit before tax grew to Rs 19.02 cr versus Rs 15.63 cr. PAT rose 25.5% YoY to Rs 15.10 cr from Rs 12.03 cr. EPS stood at Rs 6.13 versus Rs 4.88 (restated for share subdivision and bonus issue). Auditor CNK and Associates issued an unmodified limited review report, succeeding the predecessor auditor. Company operates in a single segment of speciality chemicals.

Likely market impact

Strong topline and bottomline growth signals healthy operational momentum. EPS was restated due to a corporate action. Auditor change noted.